3,4,5,7-TETRA-O-BENZYL-6-[(BENZOYLOXYCARBONYL)-AMINO]-1,2,6-TRIDEOXY-D-GALACTO-HEPT-1-ENITOL
Compound with spectra: 1 NMR
![3,4,5,7-TETRA-O-BENZYL-6-[(BENZOYLOXYCARBONYL)-AMINO]-1,2,6-TRIDEOXY-D-GALACTO-HEPT-1-ENITOL](/api/compound/LPkvPNMpyrD.png?ph=true&h=300&w=458 "3,4,5,7-TETRA-O-BENZYL-6-[(BENZOYLOXYCARBONYL)-AMINO]-1,2,6-TRIDEOXY-D-GALACTO-HEPT-1-ENITOL")
| SpectraBase Compound ID | LPkvPNMpyrD |
|---|---|
| InChI | InChI=1S/C43H45NO6/c1-2-40(47-29-35-20-10-4-11-21-35)42(49-31-37-24-14-6-15-25-37)41(48-30-36-22-12-5-13-23-36)39(33-46-28-34-18-8-3-9-19-34)44-43(45)50-32-38-26-16-7-17-27-38/h2-27,39-42H,1,28-33H2,(H,44,45)/t39-,40+,41+,42-/m1/s1 |
| InChIKey | BUGSGBIJOUVJBN-BZXDADGQSA-N |
| Mol Weight | 671.8 g/mol |
| Molecular Formula | C43H45NO6 |
| Exact Mass | 671.324688 g/mol |
| Enantiomer InChIKey | BUGSGBIJOUVJBN-YIEWKAQUSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-ACETAMIDO-2,5,6,7-TETRA-O-BENZYL-3-DEOXY-D-GLYCERO-D-GALACTO-HEPTITOL
(2R,3S,4R,5S)-1,3,4-Tribenzyloxy-5-(4-methoxyphenyl)methylamino-6-hepten-2-ol
BETA-1,5-ANHYDRO-2,3,4,6-TETRA-O-BENZYL-1-C-(1'-E-HEPTENYL)-D-GLUCOPYRANOSIDE
ALPHA-1,5-ANHYDRO-1-C-(4'-METHYL-1'-PENTENYL)-2,3,4,6-TETRA-O-BENZYL-D-GLUCITOL
Methyl 2-[N-(Benzoxycarbonyl)amino]-3-O-benzyl-2,6-dideoxy-6-iodo-.alpha.-D-glucopyranoside
3,4-DI-O-BENZYL-2,5-[(6-OXYCARBONYL)-IMINO]-2,5-DIDEOXY-D-GLUCITOL
1-[4-(benzyloxy)-trans-1-butenyl]-1-deoxy-2,3,4,6-tetra-o-benzyl-beta-D-glucopyranose
DYDAVEMWGWFNJE-SLXQPGMDSA-N
BENZYL-2-AMINO-3,4,6-TRI-O-BENZYL-2-DEOXY-ALPHA-D-GLUCOPYRANOSIDE
1-(R)-2,3,5,6-TETRA-O-BENZYL-1,4-DIDEOXY-1,4-IMINO-1-C-PROPYL-D-GALACTITOL
| Title | Journal or Book | Year |
|---|---|---|
| α- and β-Homogalactonojirimycins (α- and β-Homogalactostatins) synthesis and further biological evaluation | Bioorganic & Medicinal Chemistry | 2001 |